US Pharma MarketingI&I startup Attovia files to go public as biotech listings momentum builds
Attovia files for a Nasdaq IPO under ticker ATTO, becoming the third biotech to file this month after Scribe and Apnimed. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for…
The tally of biotechs waiting to list in the coming weeks has increased to three, after biologics maker Attovia Therapeutics filed for an initial public offering on Tuesday after the market closed.
Attovia, which has ...
Source: Endpoints News